Use of Pembrolizumab Expanded to 13th Type of Cancer in Five Years
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Tag: PD-1
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...